The 15-year Cumulative Incidence and Associated Risk Factors for Retinopathy in Nondiabetic Persons

Abstract

Objective

To investigate the relationship of systemic factors to the 15-year cumulative incidence of retinopathy in nondiabetic persons in the Beaver Dam Eye Study.

Methods

Included 4,699 persons, 43-86 years of age at baseline examination in 1988-90 and with follow-up in 1993-95, and/or 1998-2000, and/or 2003-05. Stereoscopic color fundus photographs were graded to determine the presence of retinopathy. The main outcome measure was cumulative incidence of retinopathy accounting for competing risk of death or diabetes.

Results

The 15-year cumulative incidence of retinopathy in the nondiabetic cohort was 14.2%. In multivariate analyses, older age (hazard ratio [HR] per age group 1.13, 95% confidence interval [CI] 1.01-1.27), higher systolic blood pressure (BP, HR per 10 mmHg 1.15, 95% CI 1.07-1.20), presence of chronic kidney disease (CKD, HR 1.51, 95% CI 1.12-2.00) and wider retinal arteriolar diameter (HR per 10 μm 1.17, 95% CI 1.10-1.26) at baseline were associated with the incidence of retinopathy. In a separate model, the 15-year incidence of retinopathy was higher in those with uncontrolled hypertension compared with those who were normotensive (HR per 10 mmHg 1.41, 95% CI 1.05-1.89). There were no associations of body mass index, lipids, glycosylated hemoglobin, smoking status, markers of inflammation, endothelial dysfunction and oxidative stress, and hematologic factors to retinopathy incidence.

Conclusions

These data show two modifiable factors, uncontrolled hypertension and CKD, are related to an increased incidence of retinopathy in nondiabetic persons and show that control of BP is associated with a lower risk of incident retinopathy compared to uncontrolled BP.

Introduction

Retinopathy is estimated to affect between 1 and 15% of people without diabetes.^1-9 It usually involves the presence of a retinal microaneurysm or blot hemorrhage in one eye and is associated with older age and hypertension. Independent of age, hypertension and other risk factors, the presence of retinopathy in nondiabetic persons is associated with increased risk of incident hypertension, diabetes mellitus, myocardial infarction, congestive heart failure, stroke, impaired cognition, and kidney disease.^10-20 There are few long-term epidemiologic data describing the incidence and disappearance of retinopathy and associated risk factors in the nondiabetic population.²¹ The purpose of this paper is to investigate the natural history and relationship of systemic factors to the 15-year cumulative incidence and disappearance of retinopathy in nondiabetic persons in the Beaver Dam Eye Study (BDES).

Methods

Population

Methods used to identify and describe the population have appeared in previous reports.^22,23 In brief, a private census of the population of Beaver Dam, Wisconsin (99% white), was performed from fall 1987 to spring 1988 in people 43 to 84 years of age.²² Of the 5,924 eligible individuals, 4,926 participated in the baseline examination in 1988-1990.²³ Of the 4,542 surviving participants, 3,684 (81.1%) participated in the 5-year follow-up examination in 1993-1995.²⁴ Comparisons between participants and nonparticipants at baseline and the 5-year follow-up examination have appeared elsewhere.^23,24 Of the 3,334 surviving participants in the baseline and second examinations, 2,764 (82.9%) participated in the 10-year follow-up examination between March 1, 1998, and June 9, 2000.²⁵ Comparisons between participants and nonparticipants at baseline and the 10-year examination have appeared elsewhere.²⁴ Of the 2,480 surviving participants examined at the baseline, 5-year, and 10-year follow-up examinations, 2,119 (85.4%) participated in the 15-year follow-up examination between March 31, 2003, and April 30, 2005.²⁶ The mean and median times between the baseline and 15-year follow-up examination were 14.9 years (standard deviation = 0.5 year) and 14.8 years, respectively.

Comparisons between participants and nonparticipants at the 15-year follow-up have been presented elsewhere.²⁶ In general, persons who did not participate in the 15-year follow-up were older at baseline than those who did. After adjusting for age, nonparticipants were more likely to have fewer years of education completed, higher systolic blood pressure, and more pack-years smoked than persons who participated. After adjusting for age and gender, nondiabetic participants with retinopathy at baseline were as likely to participate as those without retinopathy (data not shown).

Procedures

Similar procedures were used at the baseline and follow-up examinations. Informed consent was obtained and institutional review^27-35 board approval was granted at the beginning of each examination.

Participants underwent a standardized interview and examination at each visit. Information on demographic characteristics, cigarette smoking, alcohol intake, self-reported history of physician-diagnosed diabetes, hypertension or cardiovascular disease (CVD), and medication use were obtained from the questionnaire. There were also questions regarding use of diet and oral hypoglycemic agents or insulin for the management of hyperglycemia and questions regarding history of cigarette smoking, hypertension, and use of antihypertensive medications for the management of high blood pressure. Questions were also asked about use of lipid lowering agents for the management of dyslipidemia and aspirin and other nonsteroidal anti-inflammatory agents.

Blood pressure was measured according to the Hypertension Detection and Follow-up Program protocol.³⁰ Nonfasting serum glucose level was determined using the hexokinase method,³¹ and plasma glycosylated hemoglobin was determined using affinity chromatography (Isolab Inc., Akron, OH).³² White blood cell count, red blood cell count and platelet count were determined using a Coulter counter method.

At the baseline and follow-up examinations, additional blood samples were stored in freezers at -80°C until the time of laboratory analysis. Baseline frozen samples were analyzed for serum creatinine, cystatin C, high sensitivity C-reactive protein (CRP), interleukin-6 (IL-6) and isoprostane levels.

Stereoscopic 30° color fundus photographs centered on the disc (Diabetic Retinopathy Study standard field 1) and macula (Diabetic Retinopathy Study standard field 2) and a nonstereoscopic color fundus photograph temporal to but including the fovea (modified Diabetic Retinopathy Study standard field 3) were taken in each eye.³³ Additional fundus photographs were taken if any lesions were found outside these fields.

Retinopathy was defined using a classification derived from studies of diabetic retinopathy but used herein to describe the presence of such lesions in the absence of diabetes. The presence of retinal hemorrhages, microaneurysms, cotton-wool spots, hard exudates, intraretinal microvascular abnormalities, venous beading, new vessels on the disc and elsewhere, and preretinal and vitreous hemorrhages was graded in a masked fashion using an abbreviation of the modified Airlie House classification scheme.^34,35 Retinal microaneurysms were defined as small (usually not larger than the width of a vessel at the disc margin [125 microns]), circular, hard-edged and evenly colored, while retinal blot hemorrhages were usually larger than microaneurysms (any red spot >125 microns in its longest dimension was considered a hemorrhage unless the shape, smooth margins and central light reflex suggested it was a MA), with uneven edges and coloring. The presence of other retinal disease, such as central and branch retinal arterial or venous occlusion, retinal cholesterol emboli, and surface wrinkling retinopathy was graded using a detailed protocol.

When two eyes of a participant were discrepant in the presence of a lesion, the grade assigned was that of the more severely involved eye. For example, in assigning the presence of retinal microaneurysms, if they were present in one eye but not the other, the participant would be considered to have retinal microaneurysms. When lesions could not be graded in one eye, the participant was assigned a score equivalent to that in the other eye.

After converting the field 1 photographs to digitized images, retinal measurements were carried out by trained graders masked to participant characteristics using computer-assisted software. All arterioles and venules coursing through a specified zone of 0.5–1 disc diameter surrounding the optic disc margin were measured and summarized as central retinal arteriolar equivalent (CRAE) or central retinal venular equivalent (CRVE) using a modification of the Parr-Hubbard formula³⁶ as described by Knudtson et al.³⁷ These equivalents are the projected diameters of the central retinal vessels, measured away from the optic disc.

Definitions

Age was defined as the age at the time of examination. Retinopathy was defined to include presence of microaneurysms and/or blot hemorrhages, and/or more severe retinopathy lesions (e.g., hard exudates, cotton-wool spots, intraretinal microvascular abnormalities, retinal new vessels). Retinal microaneurysms and blot hemorrhages were also analyzed separately. The mean systolic blood pressure was the average of the two systolic blood pressure determinations, and the mean diastolic blood pressure was the average of the two diastolic blood pressure determinations. A person was defined as having a positive history if he/she responded positively to the questions regarding CVD and stroke. Hypertension was defined as a mean systolic blood pressure of ≥140 mmHg, and/or a mean diastolic blood pressure of ≥90 mmHg, and/or a history of hypertension with use of antihypertensive medication. Hypertension was further characterized by antihypertensive treatment status as untreated uncontrolled, treated and controlled, or treated and uncontrolled. Diabetes was defined as a history of diabetes mellitus, treated with insulin, oral hypoglycemic agents, and/or diet. Newly diagnosed diabetes mellitus was defined by a glycosylated hemoglobin value that was greater than 2 standard deviations above the mean for a given age-sex group or a random blood glucose value >200 mg/dL. Primary care physicians were consulted whenever there was doubt about past diagnosis. Body mass index (BMI) was calculated as weight in kilograms divided by the square of height in meters.

The glomerular filtration rate was estimated from serum creatinine using the re-expressed Modification of Diet in Renal Disease equation defined as follows: estimated glomerular filtration rate (eGFR) = 175 × (serum creatinine in mg/dL)^-1.154 × age^-0.203 (× 0.742 for women).³⁸ Chronic kidney disease (CKD) was defined as eGFR < 60 mL/min/1.73 m², based on the US National Kidney Foundation Kidney Disease Outcome Quality Initiative working group definition.³⁹

Incident retinopathy, microaneurysms, and blot hemorrhages were defined in the nondiabetic cohort without retinopathy at baseline who developed these lesions at a follow-up examination before developing diabetes or a retinal vein occlusion. Disappearance was defined in a nondiabetic cohort without retinal vein occlusion who had signs of retinopathy at baseline and in whom the lesion or lesions disappeared at a follow-up examination before diabetes or a retinal vein occlusion occurred.

Cigarette smoking status was defined as follows: subjects were classified as having never smoked if they reported having smoked fewer than 100 cigarettes in their lifetime; as ex-smokers if they had smoked more cigarettes than this in their lifetime but stopped smoking before the examination; and as current smokers if they had not stopped. Visual impairment was defined as a best corrected visual acuity determined by a modified Early Treatment Diabetic Retinopathy Study refraction of 20/40 or worse in the better eye.²³

Statistical Methods

SAS (SAS Institute, Cary, NC) was used for statistical analysis.⁴⁰ Cumulative incidence was estimated by the product-limit method,⁴¹ and age-adjusted rates were computed by the direct method. Tests for differences between rates were conducted by the log-rank test.⁴² Multivariable models were constructed by discrete logistic hazard regression.⁴³ Time-varying covariates were employed as follows: for each separate 5-year follow-up interval, the value of each covariate at the beginning of the interval, or previous value if that value was missing, was included in the model. For example, the baseline value of hypertension was included for the interval between baseline and the 5-year examination. The value at the 5-year examination was included for the interval between the 5- and 10-year examinations, and the value at the 10-year examination was included for the interval between the 10- and 15-year examinations. Time-varying covariates for other parameters subject to change were defined similarly. Participants were censored at the point they developed diabetes or a retinal vein occlusion. For example, if they developed diabetes or a retinal vein occlusion between exams 2 and 3, they were censored at exam 3.

The hazard of developing retinopathy in the second eye compared to the first was modeled with a Markov multi-state model using the R software package.⁴⁴ Age was used as the time scale and diabetes and death were modeled as absorbing states. The transition rate for developing retinopathy in the right eye was constrained to be equal to that in the left eye.

Results

Of the 4,699 persons examined at baseline who had information from at least one follow-up examination, we excluded 505 persons with confirmed diabetes, suspected diabetes, or no diabetes information at baseline and 32 persons with central or branch retinal venous or arterial occlusions or neovascular age-related macular degeneration at baseline. We also excluded 185 persons with no information regarding retinopathy at baseline, 481 persons lost to follow-up at the second exam, 168 persons missing retinopathy information at follow-up, and 55 with a retinal vein occlusion at the follow-up examination, leaving 3,273 persons for analysis.

The prevalence of any retinopathy at baseline in this group was 10.1% (7.8% at risk for disappearance); for retinal microaneurysms only it was 7.1% (5.5% at risk for disappearance), for retinal blot hemorrhages only it was 2.5% (1.3% at risk for disappearance), and for more severe retinopathy it was 1.1% (0.8% at risk for disappearance). Table 1 presents characteristics of the nondiabetic group who did or did not have retinopathy at baseline and was at risk for incidence or disappearance of retinopathy. Persons with retinopathy were older, had higher glycosylated hemoglobin, higher systolic and diastolic blood pressure, higher pulse pressure, higher white blood cell count, higher serum cystatin C, and higher frequency of hypertension present than those without retinopathy present at baseline.

Table 1.

Characteristics of Participants With and Without Retinopathy in the Beaver Dam Eye Study Baseline Examination, 1988-1990.

Characteristic	No retinopathy			Retinopathy present*			P-value
	N	Mean	SD	N	Mean	SD
Age (yrs)	3017	60.1	10.57	256	63.8	10.31	<0.001
Body mass index (kg/m2)	3005	28.5	5.25	254	28.8	5.05	0.35
Glycosylated hemoglobin (%)	3017	5.7	0.68	256	5.8	0.87	0.01
Serum total cholesterol (mg/dL)	3017	232.4	43.27	256	233.2	44.30	0.77
Serum HDL cholesterol (mg/dL)	3012	52.9	17.54	256	50.8	17.33	0.07
Systolic blood pressure (mmHg)	3016	129.3	19.16	256	138.6	21.93	<0.001
Diastolic blood pressure (mmHg)	3016	77.5	10.55	256	79.1	11.22	0.03
Pulse pressure (mmHg)	3016	51.8	16.11	256	51.8	20.42	<0.001
Pack-years smoked, in smokers	1653	30.9	27.9	143	35.7	31.4	0.16
CRAE (μm)	3014	149.5	13.74	256	150.4	12.29	0.32
CRVE (μm)	3013	229.8	21.33	256	227.5	21.33	0.10
Serum C-reactive protein (mg/L)	3001	4.02	9.47	255	4.9	12.83	0.16
Serum cystatin C (mg/L)	2856	0.89	0.26	237	0.96	0.30	0.002
Hematocrit (%)	3017	43.0	3.80	256	43.4	4.11	0.08
White blood cell count (k/μL)	3016	7.22	1.97	256	7.6	2.75	0.01
Serum isoprostane (pg/mL) ‡	1074	142.2	84.52	87	147.8	105.88	0.56
Serum interleukin-6 (pg/mL) ‡	1076	3.8	15.87	87	4.3	8.55	0.76
Sex (% male)	3017	44.7		256	50.0		0.10
History of CVD (% present)	2983	11.6		255	15.3		0.08
Chronic kidney disease (% present)‡	1093	14.5		88	17.1		0.50
Hypertension (% present)	3014	44.7		256	62.9		<0.001
Microaneurysm only (% present)*†				256	69.0		-
Retinal hemorrhages only (% present)*†				256	23.0		-
Retinopathy >=level 31 (% present)*†				256	9.0		-

Abbreviations: CRAE = central retinal arteriole equivalent; CRVE = central retinal venule equivalent; CVD = cardiovascular disease.

^*At risk for disappearance

^†Not mutually exclusive

^‡Measured in subset of population only

The 15-year cumulative incidence of retinopathy, microaneurysms only, retinal hemorrhages only, and retinal microaneurysms and retinal hemorrhage or more severe retinopathy in nondiabetic persons was 14.2% (95% confidence interval [CI], 12.8 to 15.6%), 8.3% (95% CI 7.1 to 9.5%), 4.8% (95% CI 3.2 to 5.8%), and 1.2% (95% CI 0.8 to 1.6%), respectively. The hazard of developing retinopathy in the second eye when present in the other eye was 3.21 (95% CI 2.1 to 5.0) compared to developing it in the first eye.

Table 2 shows the relationship of 15-year cumulative incidence of retinopathy, microaneurysms only, retinal hemorrhages only, and more severe retinopathy by age and sex. The cumulative incidence of retinopathy and lesions characterizing it, except microaneurysms only, increased with age and was similar in men and women.

Table 2.

15-year cumulative indence of any retinopathy, microaneurysms only, blot hemorrhages only and more severe retinopathy with competing risk of death or diabetes by age and sex in nondiabetic persons in the Beaver Dam Eye Study, 1988-1990 to 2003-2005

	Any Retinopathy			Microaneurysms Only		Retinal Hemorrhage Only		More Severe Retinopathy
	N	Cumulative Incidence (%)	N*†	Cumulative Incidence (%)	N*†	Cumulative Incidence (%)	N*†	Cumulative Incidence (%)
Age group, yr
43-54	1103	13.9	1088	8.9	1061	4.0	1049	0.4
55-64	842	14.7	823	9.1	811	4.9	801	1.5
65-74	746	16.2	723	8.0	722	6.6	707	1.9
75-84	326	10.0	316	4.5	313	3.6	309	2.5
Sex
Female	1670	15.3	1628	8.4	1616	5.6	1591	1.5
Male	1347	12.9	1322	8.3	1291	3.8	1275	0.8
Age	HR	95% CI	HR	95% CI	HR	95% CI	HR	95% CI
Per 5 years	1.24	1.11–1.39	1.08	0.93–1.26	1.43	1.18–1.75	2.38	1.60–3.55
Sex (Male vs Female)	0.97	0.78–1.20	1.18	0.89–1.56	0.76	0.52–1.13	0.57	0.25–1.31

Abbreviations: HR = hazard ratio; CI = confidence interval.

^*Cumulative 15-year incidence was calculated accounting for the competing risk of death or diabetes where time to the event of interest, incidence of retinopathy or retinopathy lesion(s) or competing events, death or developing diabetes, are modeled.

^†Not mutually exclusive. N at risk varies for each lesion because of incidence of other lesions between Beaver Dam 1 and Beaver Dam 2.

Table 3 shows the relationships, after age adjustment, of various characteristics at baseline to the hazard of developing retinopathy, microaneurysms only, retinal hemorrhages only, and more severe retinopathy over the 15-year period. Uncontrolled hypertension, higher systolic blood pressure, higher pulse pressure, presence of CKD, higher cystatin C, and greater CRAE were associated with the incidence of retinopathy. There were no associations of glycosylated hemoglobin, pack years smoked, markers of inflammation, endothelial dysfunction and oxidative stress, hematologic factors (Table 3), or history of use of lipid-lowering agents or of aspirin and other nonsteroidal anti-inflammatory agents (data not shown) with the incidence of retinopathy, retinal microaneurysms only, retinal hemorrhages only, or more severe retinopathy. In multivariable analyses (Figure 1) and in multivariable models with time-dependent covariates (data not shown), these associations with the incidence of retinopathy remained similar.

Table 3.

Age adjusted relationships of various characteristics at baseline to the 15-year cumulative incidence of any retinopathy, retinal microaneurysms only, retinal hemorrhages only and severe retinopathy in the Beaver Dam Eye Study^*

Characteristics	Any Retinopathy		Microaneurysms Only		Retinal Hemorrhages Only		Severe Retinopathy
	HR	95% CI	HR	95% CI	HR	95% CI	HR	95% CI
Hypertension
Treated, controlled vs normal	0.93	0.64–1.34	0.92	0.56–1.51	0.97	0.52–1.80	1.11	0.34–3.58
Untreated, uncontrolled vs normal	1.27	0.96–1.69	1.45	1.02–2.08†	0.77	0.43–1.39	2.12	0.86–5.22
Treated, uncontrolled vs normal	1.92	1.40–2.64†	1.75	1.13–2.71†	2.47	1.50–4.07†	1.00	0.27–3.73
Systolic BP (per 10 mmHg)	1.10	1.04–1.17†	1.12	1.04–1.21†	1.04	0.93–1.15	1.26	1.05–1.51†
Diastolic BP (per 10 mmHg)	1.09	0.98–1.21	1.11	0.96–1.28	1.07	0.88–1.29	1.15	0.79–1.68
Pulse pressure (per 10 mmHg)	1.13	1.05–1.22†	1.15	1.04–1.27†	1.03	0.89–1.18	1.35	1.07–1.69†
Pack years smoked (in smokers, per 10 packyears)	0.94	0.88–1.01	0.96	0.88–1.04	0.93	0.82–1.04	0.99	0.75–1.31
Serum total cholesterol (per 10 mg/dL)	1.00	0.98–1.03	1.01	0.98–1.05	0.99	0.95–1.04	1.01	0.92–1.10
Serum HDL cholesterol (per 10 mg/dL)	0.98	0.92–1.04	0.95	0.88–1.04	0.98	0.88–1.10	1.18	0.98–1.43
Body mass index (per 5 kg/m2)	1.10	0.99–1.22	1.06	0.92–1.21	1.24	1.05–1.47†	0.99	0.66–1.46
Chronic kidney disease (present vs absent)	1.49	1.10–2.02†	1.48	0.98–2.23†	1.37	0.81–2.34	1.40	0.53–3.70
White blood cell count (per k/μL)‡	1.02	0.91–1.14	1.00	0.86–1.15	1.01	0.83–1.22	0.96	0.65–1.42
Hematocrit (per 1%)	1.02	0.99–1.05	1.03	0.99–1.07	1.01	0.96–1.06	1.05	0.94–1.17
Serum C-reactive protein (per mg/L)‡	0.99	0.89–1.11	0.94	0.81–1.09	0.99	0.81–1.21	1.52	1.04–2.21†
Serum isoprostane (per pg/mL)‡	1.02	0.86–1.19	0.94	0.75–1.18	1.08	0.83–1.41	0.92	0.49–1.71
Serum cystatin C (per mg/L) ‡	1.22	1.06–1.40†	1.16	0.96–1.39	1.27	0.99–1.62	1.61	1.02–2.53†
History of cardiovascular disease (present vs absent)	0.70	0.45–1.08	0.69	0.38–1.26	0.79	0.39–1.60	0.53	0.12–2.28
Sex (male)	1.00	0.80–1.24	1.19	0.90–1.58	0.80	0.54–1.18	0.67	0.29–1.55
CRAE (per 10 μm)	1.11	1.02–1.20†	1.13	1.02–1.26†	1.03	0.90–1.19	1.16	0.88–1.55
CRVE (per 10 μm)	1.01	0.96–1.07	1.02	0.95–1.09	0.95	0.86–1.04	1.11	0.93–1.33
Glycosylated hemoglobin (per %)	0.97	0.81–1.16	0.93	0.73–1.17	0.92	0.67–1.26	1.04	0.55–1.96

Abbreviations: HR = hazard ratio; CI = confidence interval; BP = blood pressure; HDL = high density lipoprotein; CRAE = central retinal arteriole equivalent; CRVE = central retinal venule equivalent.

^*Severe retinopathy defined as a Diabetic Retinopathy Study severity Level 31 or greater.

^†P-value significant at 0.05 level

^‡Variable entered per SD on the log scale

Figure 1.

Multivariate models for hazard of developing retinopathy in persons without diabetes. All models include age, chronic kidney disease (CKD), and central retinal arteriole equivalent (CRAE) and one of the following: A: Systolic BP. B: Hypertension (expanded by level of control). C: Pulse pressure. Hypertension was defined as SBP ≥140 mmHg or DBP ≥90 mmHg or use of antihypertensive medication.

The 15-year cumulative disappearance of retinopathy, microaneurysms only, retinal hemorrhages only, and retinal microaneurysms and hemorrhage or more severe retinopathy in nondiabetic persons was 70.2% (95% CI 66.3 to 74.1%), 73.6% (95% CI 67.5 to 79.7), 75.9% (95% CI 68.1 to 84.7) and 46.9% (95% CI 28.9 to 64.9%), respectively. Table 4 shows the relationship of 15-year cumulative disappearance of retinopathy, microaneurysms only, retinal hemorrhages only, and more severe retinopathy with competing risks of diabetes and death by age and sex. The disappearance of retinopathy decreased with age. Uncontrolled hypertension, higher diastolic blood pressure, and the presence of CKD were associated with decreased disappearance of retinopathy (Figure 2). Higher serum HDL cholesterol was associated with increased disappearance of retinopathy (Figure 2).

Table 4.

15-year cumulative disappearance of retinopathy microaneurysms only, blot hemorrhages only and more severe retinopathy with competing risks of diabetes and death by age and sex in nondiabetic persons in the Beaver Dam Eye Study, 1988-1990 to 2003-2005.^*

	Any Retinopathy		Microaneurysms Only		Retinal Hemorrhages Only		More Severe Retinopathy
	N	CD (%)	N*†	CD (%)	N*†	CD (%)	N*†	CD (%)
Age group
43-54	57	90.9	49	93.5	6	83.3	1	0.0
55-64	75	70.7	54	73.4	13	76.9	5	40.0
65-74	85	67.8	47	66.8	23	91.3	7	57.1
75-84	39	41.0	19	31.6	16	50.0	3	0.0
Sex
Female	128	77.6	82	86.9	34	76.5	8	25.0
Male	128	63.0	87	62.7	24	75.0	8	50.0

Abbreviations: CD = cumulative disappearance.

^*Cumulative 15-year disappearance was calculated accounting for the competing risk of death or diabetes where time to the event of interest, disappearance of retinopathy or lesion(s) or competing events, death or developing diabetes, are modeled.

^†Not mutually exclusive. N at risk varies for each lesion due to incidence of other lesions between Beaver Dam 1 and Beaver Dam 2.

Figure 2.

Multivariate models for hazard of disappearance of retinopathy in persons without diabetes. CKD = chronic kidney disease; CRAE = central retinal arteriole equivalent.

Controlling for age, there was no difference in incidence of visual impairment at a subsequent visit for individuals who had retinopathy at the previous visit compared to those who did not (p=0.77). Similarly, there was no significant decrease in mean number of letters read at a subsequent visit for individuals who had retinopathy at the previous visit compared to those who did not (p=0.45).

Discussion

There are few long-term epidemiological population-based data describing the appearance and disappearance of retinopathy and associated risk factors in persons without diabetes.²¹ Over a 15-year period, 14% of nondiabetic persons in the Beaver Dam Eye Study cohort developed retinopathy and it disappeared in 70%. While controlling for age, poorly controlled blood pressure, presence of CKD, and wider retinal arterioles at baseline were associated with the 15-year cumulative incidence and higher diastolic blood pressure, total serum cholesterol, and cystatin C and the presence of CKD were associated with the 15-year disappearance of retinopathy.

The finding of a 14% cumulative incidence of retinopathy in nondiabetic persons is lower than the 16% 10-year cumulative incidence of retinopathy in nondiabetic persons 49 years of age or older reported in the Blue Mountains Eye Study (BMES).²¹ In both studies, retinopathy incidence was detected by assessment of stereoscopic color fundus photographs using the same grading protocols. The higher incidence of retinopathy in the BMES cohort may be due to the larger area of the fundus that was photographed (6 vs. 3 standard fields) in that study compared to the BDES. Based on our findings, we estimate that retinopathy will develop in 3,469,334 white nondiabetic persons 43-86 years of age in the US population over a 15-year period. This has public health implications because nondiabetic persons with retinopathy are at higher risk of developing systemic disease, e.g., ischemic heart disease, congestive heart failure, stroke, cognitive decline, and CKD than people without retinopathy.^10-20

In the Beaver Dam Eye Study, uncontrolled blood pressure was associated with an increased likelihood of developing retinopathy and a decreased likelihood of its disappearance. Our findings are consistent with data from other studies and were not unexpected because of the known effects of blood pressure on the retinal microvasculature.^1-4,6,8,42 This may represent a potential public health burden based on previous observations of increased risk of cardiovascular morbidity and mortality in persons with uncontrolled hypertension and signs of retinopathy.^1,2,4,17,45

In the Beaver Dam Eye Study, independent of hypertension status, CKD was associated with an increased risk of incident retinopathy and a decreased risk of its disappearance. This is not unexpected because renal disease is associated with hypertension, inflammation and endothelial dysfunction, all hypothesized as pathogenetic factors for the development of retinopathy.^46-48 However, this relation remained when controlling for these factors in multivariate analyses, suggesting that other unmeasured pathogenetic mechanisms associated with kidney disease may be involved in the development of retinopathy in nondiabetic persons. It is also possible that hypertension and perhaps elevated levels of inflammatory factors are causally associated with CKD and that we are measuring the residual effects of those relationships.

The relationship of wider retinal arterioles with increased risk of incident retinopathy was unexpected. We had hypothesized that narrower retinal arteriole diameters would be associated with hypertension and related to retinopathy and that wider venular diameters would be associated with systemic inflammation and endothelial dysfunction and related to incident retinopathy.^7,49,50 Increased CRAE could be related to increased retinal blood flow, which has been posited as a candidate mechanism for retinopathy pathogenesis through hemodynamic injury in people with diabetes.^51-53

In the BDES, retinopathy was transient when it appeared, with disappearance in 70% of nondiabetic persons over the 15-year period, usually within the five-year interval between visits and with no effect on vision. This is unlike the presence of minimal retinopathy in persons with diabetes, which is likely to progress and less likely to disappear.^54,55 This brings into question whether a single retinal microaneurysm or retinal hemorrhage is a valid diagnostic criterion for defining the presence of diabetes in the general population. These findings also raise the question of whether the presence of a single retinal microaneurysm or blot hemorrhage in the eye of a hypertensive person with type 2 diabetes mellitus should be considered diabetic retinopathy.

A number of hypothesized risk factors, e.g., smoking status and glycemic, hematologic and inflammatory factors were not found to be associated with incident retinopathy in our study. With the exception of smoking, these factors have been shown to be associated with incident retinopathy in persons with diabetes.⁵⁶ The association of hypertension and the lack of an association of glycosylated hemoglobin in nondiabetic persons with incident retinopathy suggests that the pathogenesis of these lesions is more likely due to the effects of high blood pressure itself on the retinal microvasculature, and less likely due to hyperglycemia related pathways.

Any conclusions or explanations regarding associations described herein must be made with caution. For example, a possible reason for not finding a relation between smoking and the incidence of retinopathy is that persons who smoked and developed retinopathy may have died before their follow-up examination was performed. Second, the retinopathy might have resulted from conditions in nondiabetic persons that were not asked about or determined in the study, such as acquired immune deficiency syndrome or aplastic anemia.⁵⁷ These conditions are rare in this population and would not be expected to account for the high incidence of the retinal lesions found in the nondiabetic group. Third, misclassification of hypertension status may have occurred, because the classification was based, in part, on two measurements of the blood pressure during a single examination. This type of misclassification would likely weaken the significant relationship found between hypertensive status and the presence of retinal lesions in nondiabetic persons.

In summary, the data from this study show a 14% 15-year cumulative incidence of retinopathy in nondiabetic persons. The findings also show that two modifiable risk factors, uncontrolled hypertension and CKD, are related to incident retinopathy in nondiabetic persons. While retinopathy in nondiabetic persons is usually transient and in itself does not affect visual function, its clinical significance is as a marker for increased risk of CVD morbidity and mortality and other systemic diseases. A report by Wong et al. illustrates this, showing a multiplicative effect of jointly having retinopathy and cerebral white matter lesions with the 5-year relative risk of incident stroke.¹¹ The latter varied from 1.4% when neither were present to about 4% when either was present to nearly 20% (RR 20) when both were present in the general Atherosclerosis Risk In Communities study population 43-72 years of age. At present, the finding of retinopathy in nondiabetic hypertensive persons should be thought of as a possible indicator of increased risk of systemic conditions such as ischemic heart disease and stroke. While control of blood pressure has been shown to reduce the risk of cardiovascular disease, it is not known whether such control would have greater impact on hypertensive persons with retinopathy present than in those in whom it is absent.